Inventor
DAVID COREY
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C12NMicroorganisms or enzymes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07KPeptides8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
PatentTitleYear
11,840,690Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat202311,795,457Compositions and methods for treatment of Friedreich's Ataxia202311,459,564Modulation of frataxin expression202211,260,073Compounds and methods for modulating C90RF722022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to UNIV TEXAS (4)· patent assignee history
2022Patents assigned to IONIS PHARMACEUTICALS INC (2)· patent assignee history
2022–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 4 | 2022–2023 |
| IONIS PHARMACEUTICALS INC | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2023 |